🇺🇸 FDA

Drug profile · INN

pimavanserin tartrate

NUPLAZID

approved
US status
approved
Patents linked
8
News articles
0

Quick answer

pimavanserin tartrate (NUPLAZID) is an FDA-listed pharmaceutical active ingredient. Associated with Acadia Pharmaceuticals B.V.. Route of administration: oral. Current US regulatory status: approved.

Key facts

INN pimavanserin tartrate
Brand NUPLAZID
Route ORAL
Formulation CAPSULE
Originator Acadia Pharmaceuticals B.V.

Related patents

Search patents →

  1. US 11464768

    Pimavanserin alone or in combination for use in the treatment of Alzheimer's disease psychosis

    Expires Mon Oct 06 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  2. US 11452721

    Formulations of pimavanserin

    Expires Mon Sep 22 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  3. US 11191757

    Combination of pimavanserin and cytochrome P450 modulators

    Expires Mon Dec 02 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  4. US 11135211

    Pimavanserin for treating impulse control disorder

    Expires Mon Sep 30 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  5. US 10953000

    Combination of pimavanserin and cytochrome P450 modulators

    Expires Mon Mar 18 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  6. US 10849891

    Formulations of pimavanserin

    Expires Mon Nov 26 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  7. US 10646480

    Formulations of pimavanserin

    Expires Mon May 07 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  8. US 10517860

    Combination of pimavanserin and cytochrome P450 modulators

    Expires Mon Dec 26 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

Frequently asked questions

What is pimavanserin tartrate?

pimavanserin tartrate (NUPLAZID) is an FDA-listed pharmaceutical active ingredient. Associated with Acadia Pharmaceuticals B.V.. Route of administration: oral. Current US regulatory status: approved.

What is the brand name for pimavanserin tartrate?

NUPLAZID is a marketed brand name for pimavanserin tartrate. Check FDA Drugs@FDA for the current US label holder and prescribing information.

What is the US approval status of pimavanserin tartrate?

pimavanserin tartrate has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.